Vasamed Current Ratio vs. Working Capital

VSMD Stock  USD 0.0001  0.00  0.00%   
Based on the measurements of profitability obtained from Vasamed's financial statements, Vasamed may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in May. Profitability indicators assess Vasamed's ability to earn profits and add value for shareholders.
For Vasamed profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Vasamed to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Vasamed utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Vasamed's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Vasamed over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
Please note, there is a significant difference between Vasamed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vasamed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vasamed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Vasamed Working Capital vs. Current Ratio Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Vasamed's current stock value. Our valuation model uses many indicators to compare Vasamed value to that of its competitors to determine the firm's financial worth.
Vasamed is rated first in current ratio category among related companies. It is rated first in working capital category among related companies reporting about  433,333  of Working Capital per Current Ratio. Comparative valuation analysis is a catch-all model that can be used if you cannot value Vasamed by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Vasamed's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vasamed's earnings, one of the primary drivers of an investment's value.

Vasamed Working Capital vs. Current Ratio

Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Vasamed

Current Ratio

 = 

Current Asset

Current Liabilities

 = 
0.33 X
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Vasamed

Working Capital

 = 

Current Assets

-

Current Liabilities

 = 
143 K
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.

Vasamed Working Capital Comparison

Vasamed is currently under evaluation in working capital category among related companies.

Vasamed Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Vasamed, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Vasamed will eventually generate negative long term returns. The profitability progress is the general direction of Vasamed's change in net profit over the period of time. It can combine multiple indicators of Vasamed, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Vasamed Incorporated designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States. The company was founded in 1988 and is headquartered in Eden Prairie, Minnesota. Vasamed operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange.

Vasamed Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Vasamed. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Vasamed position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Vasamed's important profitability drivers and their relationship over time.

Use Vasamed in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vasamed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vasamed will appreciate offsetting losses from the drop in the long position's value.

Vasamed Pair Trading

Vasamed Pair Trading Analysis

The ability to find closely correlated positions to Vasamed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vasamed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vasamed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vasamed to buy it.
The correlation of Vasamed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vasamed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vasamed moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vasamed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Vasamed position

In addition to having Vasamed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Israel Wall Street Thematic Idea Now

Israel Wall Street
Israel Wall Street Theme
Cross-sector collection of best publicly traded Israel entities that are expected to continue growing. The Israel Wall Street theme has 71 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Israel Wall Street Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Complementary Tools for Vasamed Pink Sheet analysis

When running Vasamed's price analysis, check to measure Vasamed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vasamed is operating at the current time. Most of Vasamed's value examination focuses on studying past and present price action to predict the probability of Vasamed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vasamed's price. Additionally, you may evaluate how the addition of Vasamed to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Commodity Directory
Find actively traded commodities issued by global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
To fully project Vasamed's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Vasamed at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Vasamed's income statement, its balance sheet, and the statement of cash flows.
Potential Vasamed investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Vasamed investors may work on each financial statement separately, they are all related. The changes in Vasamed's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Vasamed's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.